We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Antibody Hinders Growth of Gleevec-Resistant Gastrointestinal Tumors in Lab Test

An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice.
News

BioLineRx Announces Offering of American Depositary Shares

Offering is expected to close on or about February 11, 2013.
News

ClinPharm Consulting Renamed to Kinetigen

Corporate name changed to establish a unique brand under Kinetigen.
News

Cangene Announces Agreement to Acquire Late Stage Hemophilia B Product

Cangene will pay approximately $5.9 million upfront for IB1001.
News

Pharmatek Announces Acquisition of Additional Xcelodose® 600S System

Acquisition enables increased capacity to meet growing demand for powder in a capsule.
News

ICON to Acquire Clinical Trial Services Division of Cross Country Healthcare Inc

Acquisition expands ICON’s global resourcing, FSP and safety capabilities.
News

Patheon Announces First Phase of Additional Investment in Milton Park Facility

UK facility to expand early development capabilities in Europe.
News

Almac Audubon Facility Passes FDA Inspection

Company launches US commercial packaging operations.
News

BioFocus Announces Agreement with ChanTest

BioFocus expands ion channel offering.
News

3D Printed Human Organs for Testing and Transplantation

Process could pave the way to purpose-built replacement organs for patients, eliminating the need for organ donation, immune suppression and the problem of transplant rejection.
Advertisement